Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Lines01:16

Cell Lines

9.9K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The utility of artificial intelligence for DNA variant curation in the Mendelian genetic disorder familial hypercholesterolaemia.

Pathology·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026
Same author

Optimizing Bispecific Antibody Expression via Multi-Omics Analysis and Vector Redesign.

Biotechnology and bioengineering·2026
Same author

SEC-seq reveals translation-focused metabolic strategies for high IgG productivity in clonal CHO cells.

bioRxiv : the preprint server for biology·2026
Same author

Maternal influenza vaccine reduces the risk of RSV and related respiratory hospitalisations in early infancy: an epidemiological study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Socio-economic inequality underpins inequity in influenza vaccination uptake between public and private secondary schools: an Australian population-based study.

The Lancet regional health. Western Pacific·2025

Related Experiment Video

Updated: Jan 1, 2026

Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

49.0K

Methods for Estimating the Probability of Clonality in Cell Line Development.

Chun Chen1, Kim Le1, Huong Le1

  • 1Drug Substance Technologies, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA.

Biotechnology Journal
|December 17, 2019
PubMed
Summary

This review compares methods for estimating the probability of clonality (PoC) in mammalian cell banks for biopharmaceutical production. Standardizing PoC estimation is crucial for comparing cloning workflows and accelerating regulatory approval.

Keywords:
cell line developmentclonalityimaginglimiting dilutionprobability of clonality

More Related Videos

Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.7K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.7K

Related Experiment Videos

Last Updated: Jan 1, 2026

Clonogenic Assay: Adherent Cells
05:30

Clonogenic Assay: Adherent Cells

Published on: March 13, 2011

49.0K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.7K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.7K

Area of Science:

  • Biopharmaceutical Manufacturing
  • Cell Line Development
  • Molecular Biology

Background:

  • Mammalian cell banks are critical for biopharmaceutical production, typically originating from a single progenitor cell.
  • Ensuring clonal origin is essential for product consistency and regulatory compliance.
  • Various methods exist to estimate the probability of clonality (PoC) for cell banks.

Purpose of the Study:

  • To systematically analyze and compare existing methods for calculating the PoC.
  • To highlight the need for a standardized approach to PoC estimation.
  • To facilitate the comparison of different cloning workflows in the biopharmaceutical industry.

Main Methods:

  • Systematic literature review and analysis of PoC calculation methods.
  • Comparative assessment of methodologies based on reported data and technological advancements.
  • Discussion of the impact of evolving single-cell deposition and imaging technologies.

Main Results:

  • A comprehensive overview of current PoC estimation techniques is presented.
  • Identified variations and limitations in existing methods.
  • Highlighted the growing importance of accurate PoC determination with technological advancements.

Conclusions:

  • An aligned understanding and best practice for PoC estimation are necessary.
  • Standardized PoC assessment will enable effective comparison of cloning workflows.
  • Improved PoC estimation will accelerate regulatory acceptance for biopharmaceutical production.